Comparison of lateral flow technology and galactomannan and (1→3)-β-D-glucan assays for detection of invasive pulmonary aspergillosis

Clinical and Vaccine Immunology

Volumn 16, Issue 12, 2009, Pages 1844-1846

  Wiederhold, Nathan P ^a,c   Thornton, Christopher R ^b   Najvar, Laura K ^c,d   Kirkpatrick, William R ^c,d   Bocanegra, Rosie ^c,d   Patterson, Thomas F ^c,d  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN; GLUCAN;

ANALYTIC METHOD; ANIMAL MODEL; ARTICLE; ASSAY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; GUINEA PIG; LATERAL FLOW TECHNOLOGY; LUNG ASPERGILLOSIS; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS; BETA-GLUCANS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; GUINEA PIGS; IMMUNOASSAY; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 73449112634     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00268-09     Document Type: Article

References (9)

1. Balloy, V., M. Huerre, J. P. Latge, and M. Chignard. 2005. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect. Immun. 73:494-503.
2. Caillot, D., O. Casasnovas, A. Bernard, J. F. Couaillier, C. Durand, B. Cuisenier, E. Solary, F. Piard, T. Petrella, A. Bonnin, G. Couillault, M. Dumas, and H. Guy. 1997. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol. 15:139-147.
3. Maertens, J., K. Theunissen, G. Verhoef, J. Verschakelen, K. Lagrou, E. Verbeken, A. Wilmer, J. Verhaegen, M. Boogaerts, and J. Van Eldere. 2005. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin. Infect. Dis. 41:1242-1250.
4. Marr, K. A., M. Laverdiere, A. Gugel, and W. Leisenring. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40:1762-1769.
5. Odabasi, Z., G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R. J. Ridge, P. A. Ketchum, M. A. Finkelman, J. H. Rex, and L. Ostrosky-Zeichner. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
6. Pfeiffer, C. D., J. P. Fine, and N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427.
7. Senn, L., J. O. Robinson, S. Schmidt, M. Knaup, N. Asahi, S. Satomura, S. Matsuura, B. Duvoisin, J. Bille, T. Calandra, and O. Marchetti. 2008. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis. 46:878-885.
8. Thornton, C. R. 2008. Development of an immunochromatographic lateral flow device for rapid serodiagnosis of invasive aspergillosis. Clin. Vaccine Immunol. 15:1095-1105.
9. Vallor, A. C., W. R. Kirkpatrick, L. K. Najvar, R. Bocanegra, M. C. Kinney, A. W. Fothergill, M. L. Herrera, B. L. Wickes, J. R. Graybill, and T. F. Patterson. 2008. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob. Agents Chemother. 52:2593-2598.